Part,  Chapter, Paragraph

1  III,    10.  2.  4|   technologies such as tissue microarrays (so-called TMAs) have the
2  III,    10.  2.  4|   2001): Validation of tissue microarrays for immunohistochemical
3  III,    10.  2.  4| Kallioniemi OP (1998): Tissue microarrays for high-throughput molecular
4  III,    10.  2.  4|       Sauter G (2001): Tissue microarrays for rapid linking of molecular